J Vet Sci, 2017 · DOI: https://doi.org/10.4142/jvs.2017.18.3.377 · Published: September 1, 2017
This study investigates the potential of using modified canine mesenchymal stromal cells (MSCs) that overexpress heme oxygenase-1 (HO-1) to treat spinal cord injuries (SCI) in dogs. Researchers compared the effects of transplanting normal MSCs versus MSCs overexpressing HO-1 into dogs with experimentally induced SCI. They looked at functional recovery, inflammation, and neuronal regeneration. The results showed that dogs receiving MSCs overexpressing HO-1 had better functional recovery, reduced inflammation, and increased neuronal regeneration compared to those receiving normal MSCs.
MSCs overexpressing HO-1 could be developed as a cell-based therapy for treating spinal cord injuries.
Transplantation of MSC-HO-1 may lead to better functional recovery compared to traditional MSC transplantation.
HO-1 overexpression can reduce inflammation at the injury site, promoting a more favorable environment for tissue repair.